Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA)

Use

This test is the preferred method for detecting Chlamydia trachomatis and Neisseria gonorrhoeae in a variety of specimens. It uses Transcription-Mediated Amplification (TMA) technology for the qualitative detection of these pathogens. It is suitable for medical purposes but not valid for evaluating suspected sexual abuse or for forensic purposes. In some contexts, such as meeting applicable laws and regulations, culture may be required for diagnosis of C. trachomatis and N. gonorrhoeae infections. This test does not include confirmation of positive results by an alternative nucleic acid target, which should be considered depending on clinical context.